194 related articles for article (PubMed ID: 11530237)
1. Degeneration of neurons and glia in the Niemann-Pick C mouse is unrelated to the low-density lipoprotein receptor.
German DC; Quintero EM; Liang C; Xie C; Dietschy JM
Neuroscience; 2001; 105(4):999-1005. PubMed ID: 11530237
[TBL] [Abstract][Full Text] [Related]
2. Neurodegeneration in the Niemann-Pick C mouse: glial involvement.
German DC; Liang CL; Song T; Yazdani U; Xie C; Dietschy JM
Neuroscience; 2002; 109(3):437-50. PubMed ID: 11823057
[TBL] [Abstract][Full Text] [Related]
3. Selective neurodegeneration, without neurofibrillary tangles, in a mouse model of Niemann-Pick C disease.
German DC; Quintero EM; Liang CL; Ng B; Punia S; Xie C; Dietschy JM
J Comp Neurol; 2001 May; 433(3):415-25. PubMed ID: 11298365
[TBL] [Abstract][Full Text] [Related]
4. Cholesterol is sequestered in the brains of mice with Niemann-Pick type C disease but turnover is increased.
Xie C; Burns DK; Turley SD; Dietschy JM
J Neuropathol Exp Neurol; 2000 Dec; 59(12):1106-17. PubMed ID: 11138930
[TBL] [Abstract][Full Text] [Related]
5. Patterned cerebellar Purkinje cell death in a transgenic mouse model of Niemann Pick type A/B disease.
Sarna J; Miranda SR; Schuchman EH; Hawkes R
Eur J Neurosci; 2001 May; 13(10):1873-80. PubMed ID: 11403680
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological and genetic modifications of somatic cholesterol do not substantially alter the course of CNS disease in Niemann-Pick C mice.
Erickson RP; Garver WS; Camargo F; Hossain GS; Heidenreich RA
J Inherit Metab Dis; 2000 Feb; 23(1):54-62. PubMed ID: 10682308
[TBL] [Abstract][Full Text] [Related]
7. Neurodegeneration augments the ability of bone marrow-derived mesenchymal stem cells to fuse with Purkinje neurons in Niemann-Pick type C mice.
Bae JS; Furuya S; Shinoda Y; Endo S; Schuchman EH; Hirabayashi Y; Jin HK
Hum Gene Ther; 2005 Aug; 16(8):1006-11. PubMed ID: 16076258
[TBL] [Abstract][Full Text] [Related]
8. Progressive neuronal loss in the ventral posterior lateral and medial nuclei of thalamus in Niemann-Pick disease type C mouse brain.
Yamada A; Saji M; Ukita Y; Shinoda Y; Taniguchi M; Higaki K; Ninomiya H; Ohno K
Brain Dev; 2001 Aug; 23(5):288-97. PubMed ID: 11504598
[TBL] [Abstract][Full Text] [Related]
9. Molecular, anatomical, and biochemical events associated with neurodegeneration in mice with Niemann-Pick type C disease.
Li H; Repa JJ; Valasek MA; Beltroy EP; Turley SD; German DC; Dietschy JM
J Neuropathol Exp Neurol; 2005 Apr; 64(4):323-33. PubMed ID: 15835268
[TBL] [Abstract][Full Text] [Related]
10. Generation and function of astroglial lipoproteins from Niemann-Pick type C1-deficient mice.
Karten B; Hayashi H; Francis GA; Campenot RB; Vance DE; Vance JE
Biochem J; 2005 May; 387(Pt 3):779-88. PubMed ID: 15544574
[TBL] [Abstract][Full Text] [Related]
11. The natural history of cerebellar degeneration of Niemann-Pick C mice monitored in vitro.
Marschalek N; Albert F; Meske V; Ohm TG
Neuropathol Appl Neurobiol; 2014 Dec; 40(7):933-45. PubMed ID: 24889722
[TBL] [Abstract][Full Text] [Related]
12. Conditional Niemann-Pick C mice demonstrate cell autonomous Purkinje cell neurodegeneration.
Elrick MJ; Pacheco CD; Yu T; Dadgar N; Shakkottai VG; Ware C; Paulson HL; Lieberman AP
Hum Mol Genet; 2010 Mar; 19(5):837-47. PubMed ID: 20007718
[TBL] [Abstract][Full Text] [Related]
13. Identification of Novel Pathways Associated with Patterned Cerebellar Purkinje Neuron Degeneration in Niemann-Pick Disease, Type C1.
Martin KB; Williams IM; Cluzeau CV; Cougnoux A; Dale RK; Iben JR; Cawley NX; Wassif CA; Porter FD
Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31906248
[No Abstract] [Full Text] [Related]
14. Neurodegeneration in Niemann-Pick type C disease mice.
Ong WY; Kumar U; Switzer RC; Sidhu A; Suresh G; Hu CY; Patel SC
Exp Brain Res; 2001 Nov; 141(2):218-31. PubMed ID: 11713633
[TBL] [Abstract][Full Text] [Related]
15. Relevance of neuronal and glial NPC1 for synaptic input to cerebellar Purkinje cells.
Buard I; Pfrieger FW
Mol Cell Neurosci; 2014 Jul; 61():65-71. PubMed ID: 24910948
[TBL] [Abstract][Full Text] [Related]
16. Neuropathology of the acid sphingomyelinase knockout mouse model of Niemann-Pick A disease including structure-function studies associated with cerebellar Purkinje cell degeneration.
Macauley SL; Sidman RL; Schuchman EH; Taksir T; Stewart GR
Exp Neurol; 2008 Dec; 214(2):181-92. PubMed ID: 18778708
[TBL] [Abstract][Full Text] [Related]
17. Gene transfer of human acid sphingomyelinase corrects neuropathology and motor deficits in a mouse model of Niemann-Pick type A disease.
Dodge JC; Clarke J; Song A; Bu J; Yang W; Taksir TV; Griffiths D; Zhao MA; Schuchman EH; Cheng SH; O'Riordan CR; Shihabuddin LS; Passini MA; Stewart GR
Proc Natl Acad Sci U S A; 2005 Dec; 102(49):17822-7. PubMed ID: 16301517
[TBL] [Abstract][Full Text] [Related]
18. Cerebellar involvement in murine sphingomyelinosis: a new model of Niemann-Pick disease.
Tanaka J; Nakamura H; Miyawaki S
J Neuropathol Exp Neurol; 1988 May; 47(3):291-300. PubMed ID: 3130465
[TBL] [Abstract][Full Text] [Related]
19. Geranylgeranyl pyrophosphate is crucial for neuronal survival but has no special role in Purkinje cell degeneration in Niemann Pick type C1 disease.
Marschalek N; Albert F; Afshordel S; Meske V; Eckert GP; Ohm TG
J Neurochem; 2015 Apr; 133(1):153-61. PubMed ID: 25319340
[TBL] [Abstract][Full Text] [Related]
20. Early glial activation, synaptic changes and axonal pathology in the thalamocortical system of Niemann-Pick type C1 mice.
Pressey SN; Smith DA; Wong AM; Platt FM; Cooper JD
Neurobiol Dis; 2012 Mar; 45(3):1086-100. PubMed ID: 22198570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]